HybridDesign

Hybrid Design for Phase I Dose-Finding Studies

CRAN Package

The Hybrid design is a combination of model-assisted design (e.g., the modified Toxicity Probability Interval design) with dose-toxicity model-based design for phase I dose-finding studies. The hybrid design controls the overdosing toxicity well and leads to a recommended dose closer to the true maximum tolerated dose (MTD) due to its ability to calibrate for an intermediate dose. More details can be found in Liao et al. 2022 doi:10.1002/ijc.34203.

  • Version1.0
  • R versionunknown
  • LicenseGPL-3
  • Needs compilation?No
  • Last release12/15/2022

Team


Insights

Last 30 days

Last 365 days

The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.

Data provided by CRAN


Binaries


Dependencies

  • Imports2 packages